ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Articles tagged with "Lupus"

Researcher Looks for Clues to Help Treat Pediatric Lupus

Staff  |  September 1, 2011

With the support of the ACR Research and Education Foundation (REF) Awards and Grants program, Ornella Rullo, MD, has developed research that may help rheumatologists better treat pediatric patients.

Past Secrets for the Future of Lupus

David S. Pisetsky, MD, PhD  |  August 1, 2011

A stretch-limo ride with academic rheumatologists leads to reflection

Hydroxychloroquine Retinopathy Still Alive and Well

Michael F. Marmor, MD  |  May 16, 2011

How rheumatologists are affected by new guidelines from ophthalmology

CARRA

Mary Desmond Pinkowish  |  May 16, 2011

Working for Children with Rheumatic Diseases

The Calling of the “Inner Nerd”

David S. Pisetsky, MD, PhD  |  January 17, 2011

Trainees shouldn’t be afraid to live the life of lab and academic research

Immunizations and Autoimmune Disease

Vanessa Caceres  |  December 1, 2010

What is safe and what to avoid in this patient population

When Steroids Cause Psychosis

Jane P. Gagliardi, MD, MHS, Andrew J. Muzyk, PharmD, & Shannon Holt, PharmD  |  October 1, 2010

Medical management of this side effect is complicated in rheumatology patients.

TNF Blockade for SLE

Martin Aringer, MD, and Maria Dall’Era, MD  |  September 1, 2010

Reckless approach versus missed opportunity?

Mitigate Risk and Increase Success of Lupus Clinical Trials

Andrea Peirce, Peter Lipsky, MD, and Benjamin D. Schwartz, MD, PhD  |  August 1, 2010

Design strategies from a Lupus Research Institute conference

When Lupus Research is a Family Affair

Cynthia Aranow, MD, Meggan Mackay, MD,Peter Gregersen, MD, and Betty Diamond, MD  |  June 1, 2010

Following sisters of SLE patients may shed light on risk factors and progression of the disease

  • « Previous Page
  • 1
  • …
  • 15
  • 16
  • 17
  • 18
  • 19
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences